In this review we summarize the results of recent cardiovascular outcome trials and discuss the potential clinical advantage of SGLT2 inhibitors and GLP-1 receptor agonists
Be Flexible Changing habits can be difficult, so start with small changes over time with an occasional cheat day or treat
In a recent Managed Healthcare Executive pharmacy survey, plan sponsors, providers and others were asked, How should payers respond to the rising cost of prescriptions for the GLP-1 drugs for weight loss? Most replied that such drugs should be covered only after other options have been tried first
Analytical validation standards applicable to research-compound quality testing
However, their effectiveness and risks have not yet been systematically evaluated in a comprehensive set of possible health outcomes
Nooms GLP-1 Companion provides continued coaching, community support, and psychology-based tools designed to help you keep the weight off even after medication ends